SK280492B6 - Očný prípravok so zníženou viskozitou - Google Patents

Očný prípravok so zníženou viskozitou Download PDF

Info

Publication number
SK280492B6
SK280492B6 SK1239-96A SK123996A SK280492B6 SK 280492 B6 SK280492 B6 SK 280492B6 SK 123996 A SK123996 A SK 123996A SK 280492 B6 SK280492 B6 SK 280492B6
Authority
SK
Slovakia
Prior art keywords
weight
amount
ophthalmic
viscosity
formulation
Prior art date
Application number
SK1239-96A
Other languages
English (en)
Slovak (sk)
Other versions
SK123996A3 (en
Inventor
Esko Pohjala
Kari Lehmussaari
Timo Reunamki
Eija Vartiainen
Olli Oksala
Sakari Alaranta
Original Assignee
Santen Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Oy filed Critical Santen Oy
Publication of SK123996A3 publication Critical patent/SK123996A3/sk
Publication of SK280492B6 publication Critical patent/SK280492B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK1239-96A 1994-03-31 1995-03-29 Očný prípravok so zníženou viskozitou SK280492B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9401108A SE9401108D0 (sv) 1994-03-31 1994-03-31 Ophthalmic composition I
PCT/FI1995/000166 WO1995026711A1 (en) 1994-03-31 1995-03-29 Ophthalmic composition with decreased viscosity

Publications (2)

Publication Number Publication Date
SK123996A3 SK123996A3 (en) 1997-06-04
SK280492B6 true SK280492B6 (sk) 2000-03-13

Family

ID=20393511

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1239-96A SK280492B6 (sk) 1994-03-31 1995-03-29 Očný prípravok so zníženou viskozitou

Country Status (27)

Country Link
US (1) US5710182A (no)
EP (1) EP0752847B1 (no)
JP (1) JPH10503470A (no)
KR (1) KR100365914B1 (no)
CN (1) CN1112918C (no)
AT (1) ATE202921T1 (no)
AU (1) AU694497B2 (no)
BG (1) BG63145B1 (no)
BR (1) BR9507438A (no)
CA (1) CA2186734A1 (no)
CZ (1) CZ290987B6 (no)
DE (2) DE69521686T2 (no)
DK (1) DK0752847T3 (no)
EE (1) EE03661B1 (no)
ES (1) ES2161874T3 (no)
GR (1) GR3036763T3 (no)
HK (1) HK1013953A1 (no)
HU (1) HU223071B1 (no)
MX (1) MX9603918A (no)
NO (1) NO314434B1 (no)
PL (1) PL179433B1 (no)
PT (1) PT752847E (no)
RO (1) RO115409B1 (no)
RU (1) RU2139016C1 (no)
SE (1) SE9401108D0 (no)
SK (1) SK280492B6 (no)
WO (1) WO1995026711A1 (no)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9718568D0 (en) 1997-09-03 1997-11-05 Chauvin Pharmaceuticals Limite Compositions
WO2000064528A1 (en) 1999-04-28 2000-11-02 Situs Corporation Drug delivery system
US6852688B2 (en) 2000-03-10 2005-02-08 University Of Florida Compositions for treating diabetic retinopathy and methods of using same
US20050089545A1 (en) * 2002-02-22 2005-04-28 Mitsuaki Kuwano Drug delivery system for the subconjunctival administration of fine grains
AU2003213210A1 (en) * 2002-02-22 2003-09-09 Pharmacia Corporation Ophthalmic formulation with gum system
JP2004196787A (ja) * 2002-12-04 2004-07-15 Santen Pharmaceut Co Ltd 結膜下デポによるドラッグデリバリーシステム
AU2003289127A1 (en) * 2002-12-04 2004-06-23 Santen Pharmaceutical Co., Ltd. Drug delivery system using subconjunctival depot
JP4860475B2 (ja) * 2003-06-13 2012-01-25 アルコン，インコーポレイテッド ２種のポリマーの相乗作用的組み合わせを含む眼科用組成物
US7947295B2 (en) * 2003-06-13 2011-05-24 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
CN1835735B (zh) * 2003-08-20 2010-05-12 参天制药株式会社 微粒眼球筋膜下给药的药物释放系统
TWI367098B (en) * 2004-12-23 2012-07-01 Kowa Co Treating agent for glaucoma
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
DE102005035986B4 (de) * 2005-07-28 2009-10-15 Bausch & Lomb Incorporated Steriles tropfbares mehrphasiges emulgatorfreies ophthalmisches Präparat
EP2334686B1 (en) 2008-08-28 2019-02-27 President and Fellows of Harvard College Cortistatin analogues and syntheses therof
EP2383286A1 (en) 2010-04-30 2011-11-02 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and compositions for treatment of retinal degenerative diseases
TW201309343A (zh) * 2011-02-10 2013-03-01 參天製藥股份有限公司 經改善親水性藥物之藥物移行性之水性組成物
US20150038557A1 (en) 2012-02-24 2015-02-05 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods and compositions for treatment of retinal degenerative diseases
MY180383A (en) 2013-12-24 2020-11-28 Harvard College Cortistatin analogues and syntheses and uses thereof
EP3294298A4 (en) 2015-05-08 2018-10-17 President and Fellows of Harvard College Cortistatin analogues, syntheses, and uses thereof
EP3316889A4 (en) 2015-07-01 2018-11-14 President and Fellows of Harvard College Cortistatin analogues and syntheses and uses thereof
AR106018A1 (es) 2015-08-26 2017-12-06 Achillion Pharmaceuticals Inc Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos
EP3340982B1 (en) 2015-08-26 2021-12-15 Achillion Pharmaceuticals, Inc. Compounds for treatment of immune and inflammatory disorders
US11583528B2 (en) 2016-02-17 2023-02-21 Children's Medical Center Corporation FFA1 (GPR40) as a therapeutic target for neural angiogenesis diseases or disorders
MX2018016046A (es) 2016-06-27 2019-05-02 Achillion Pharmaceuticals Inc Quinazolina y compuestos indol para tratar trastornos medicos.
WO2018033854A1 (en) * 2016-08-15 2018-02-22 Santen Pharmaceutical Co., Ltd. Ophthalmic composition and a method for treating ocular hypertension and glaucoma
CN109803652A (zh) 2016-08-19 2019-05-24 阿拉西斯医药公司 眼科药物组合物及其相关用途
EP3589628A4 (en) 2017-03-01 2021-03-31 Achillion Pharmaceuticals, Inc. ARYL, HETEROARYL AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF MEDICAL DISEASES
CA3063228C (en) * 2017-05-11 2022-06-28 Nevakar Inc. Atropine pharmaceutical compositions
WO2019191112A1 (en) 2018-03-26 2019-10-03 C4 Therapeutics, Inc. Cereblon binders for the degradation of ikaros
EP3841086A4 (en) 2018-08-20 2022-07-27 Achillion Pharmaceuticals, Inc. PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF MEDICAL DISORDERS RELATED TO COMPLEMENT FACTOR D
EP3866773B1 (en) 2018-10-16 2024-08-28 Georgia State University Research Foundation, Inc. Carbon monoxide prodrugs for the treatment of medical disorders
CA3205883A1 (en) * 2021-02-04 2022-08-11 Gregory I. Ostrow Ophthalmic compositions for presbyopia
EP4088713A1 (en) 2021-05-10 2022-11-16 Warszawskie Zaklady Farmaceutyczne Polfa S.A. Ophthalmic pharmaceutical composition comprising atropine
EP4088714A1 (en) 2021-05-10 2022-11-16 Warszawskie Zaklady Farmaceutyczne Polfa S.A. Ophthalmic pharmaceutical composition comprising atropine
CN113786380A (zh) * 2021-09-18 2021-12-14 华北制药股份有限公司 一种硝酸毛果芸香碱眼用凝胶及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6056684B2 (ja) * 1977-11-07 1985-12-11 東興薬品工業株式会社 点眼剤
US5252318A (en) * 1990-06-15 1993-10-12 Allergan, Inc. Reversible gelation compositions and methods of use
FR2678832B1 (fr) * 1991-07-10 1995-03-17 Europhta Sa Laboratoire Nouvelles compositions ophtalmiques a resorption amelioree et leurs procedes de preparation.

Also Published As

Publication number Publication date
BG100915A (en) 1997-07-31
HU223071B1 (hu) 2004-03-01
US5710182A (en) 1998-01-20
SE9401108D0 (sv) 1994-03-31
NO964070D0 (no) 1996-09-27
MX9603918A (es) 1997-04-30
PT752847E (pt) 2001-12-28
PL179433B1 (pl) 2000-09-29
EP0752847B1 (en) 2001-07-11
PL316584A1 (en) 1997-01-20
CN1112918C (zh) 2003-07-02
BR9507438A (pt) 1997-09-16
DE69521686D1 (de) 2001-08-16
NO314434B1 (no) 2003-03-24
CZ290987B6 (cs) 2002-11-13
AU2138995A (en) 1995-10-23
AU694497B2 (en) 1998-07-23
WO1995026711A1 (en) 1995-10-12
EP0752847A1 (en) 1997-01-15
DK0752847T3 (da) 2001-10-22
SK123996A3 (en) 1997-06-04
ATE202921T1 (de) 2001-07-15
EE9600120A (et) 1997-04-15
DE752847T1 (de) 1997-09-04
RO115409B1 (ro) 2000-02-28
HU9602691D0 (en) 1996-11-28
DE69521686T2 (de) 2002-04-25
BG63145B1 (bg) 2001-05-31
EE03661B1 (et) 2002-04-15
HUT75666A (en) 1997-05-28
KR970702024A (ko) 1997-05-13
CZ286596A3 (en) 1997-04-16
RU2139016C1 (ru) 1999-10-10
CA2186734A1 (en) 1995-10-12
KR100365914B1 (ko) 2003-04-16
ES2161874T3 (es) 2001-12-16
JPH10503470A (ja) 1998-03-31
CN1144477A (zh) 1997-03-05
GR3036763T3 (en) 2001-12-31
NO964070L (no) 1996-11-28
HK1013953A1 (en) 1999-09-17

Similar Documents

Publication Publication Date Title
SK280492B6 (sk) Očný prípravok so zníženou viskozitou
EP0755246B1 (en) Ophthalmic composition containing an ion sensitive, hydrophilic polymer and an inorganic salt in a ratio which gives low viscosity
US4425344A (en) Compositions for the treatment of glaucoma containing triamterene
JPH07508030A (ja) カルシウムアンタゴニストと公知の抗緑内障薬との組合せを含む眼局所用組成物
EP0655911B1 (en) Ophthalmological preparation
US5554367A (en) Compositions for treatment of glaucoma
PL172503B1 (pl) Oftalmiczny srodek do podawania miejscowego zawierajacy pólwodzian (S)-tymololu PL PL PL PL
RU2100020C1 (ru) Средство для местного лечения глазной гипертензии и глаукомы и способ его получения
EP0728480A1 (en) Use of ifenprodil for treatment of elevated intraocular pressure
FI117921B (fi) Alennetun viskositeetin omaava oftalminen koostumus

Legal Events

Date Code Title Description
MK4A Patent expired

Expiry date: 20150329